Paolino, G., Di Nicola, M.R., Cantisani, C. and Mercuri, S.R. (2021) Pityriasis Rosea Infection in a Covid-19 Patient Successfully Treated with Systemic Steroid and Antihistamine via Telemedicine: Literature Update of a Possible Prodromal Symptom of an Underlying SARS-CoV-2 Infection. Dermatologic Therapy, 34, e14972.
https://doi.org/10.1111/dth.14972

has been cited by the following article:

• TITLE: Pityriasis Rosea-Like Eruption by Covid-19 Infection: A New Case Report

  AUTHORS: Waqas S. Abdulwahhab, Zainab Wissam Al-Obaidy, Teba Basil Al-Khalidi, Yasmeen Wissam Al-Obaidy

  KEYWORDS: Pityriasis Rosea, Covid-19, Human Herpesvirus, Pityriasis Rosea-Like Eruption

  JOURNAL NAME: Journal of Cosmetics, Dermatological Sciences and Applications, Vol.13 No.1, March 27, 2023

  ABSTRACT: Background: Coronavirus disease (Covid-19) becomes a pandemic worldwide in 2020. Different dermatological manifestations associated with Covid-19 infection like maculopapular, morbilliform, urticarial, vesicular, chilblain-like, petechiae, purpura, and livedoid rashes. Pityriasis rosea (PR) and PR-like eruptions were recently reported to increase in coronavirus cases. Aim: To evaluate and review the literature on PR and PR-like eruption associated with Covid-19 disease. Case Report: A 24-year-old female patient presented with a history of asymptomatic PR-like eruption that started during infection with the Covid-19 virus and resolved spontaneously over 14 weeks without therapy. Conclusion: PR and PR-like eruptions are not uncommon with Covid-19 disease and could be the early manifestation of SARS-CoV-2 virus infection.